| Literature DB >> 29054122 |
Calvin Lo1, Dominik Mertz1,2,3,4, Mark Loeb1,3,4.
Abstract
BACKGROUND: High-quality reporting of outbreak characteristics is fundamental to understand the behaviour of various strains of influenza virus and the impact of outbreak management strategies. However, few studies have systematically evaluated the quality of outbreak reporting.Entities:
Keywords: STROBE statement; influenza; outbreaks; reporting criterion; reporting quality
Mesh:
Year: 2017 PMID: 29054122 PMCID: PMC5705690 DOI: 10.1111/irv.12516
Source DB: PubMed Journal: Influenza Other Respir Viruses ISSN: 1750-2640 Impact factor: 4.380
Figure 1Flow diagram of outbreak reports included and excluded. † Search terms: Outbreak or flu
Description of the Modified STROBE checklist and frequency of accurate reporting in the 64 outbreak reports assessed10, 76
| Modified STROBE Component | Component Description | n (%) Accurately Reported |
|---|---|---|
| 1) Title and Abstract | a) Either title, abstract or both sections clearly indicated study design. | 39 (61) |
| b) Study's focus and investigation details within title, abstract or both sections (eg, Influenza subtype, Geographic Location, Setting) were clearly elicited | 39 (61) | |
| c) Informative summary provided in the abstract discussing steps taken along with investigation findings | 63 (98) | |
| 2) Introduction | a) Scientific background, evidence and rationale provided for reporting and conducting investigation | 64 (100) |
| b) Specific objectives for study stated, include pre‐established hypotheses if applicable | 57 (89) | |
| c) Specific quantities provided: for example number of outbreak(s)/communities reported, number of patients from influenza outbreak (suspected, confirmed, total, etc.) | 64 (100) | |
| d) A timeline of the study was provided: includes start/finish dates of conducted investigation or outbreak | 31 (48) | |
| 3) Methods | a) Present key elements of study design early in report | 61 (95) |
| b) Was decision to report prompted by any outcome data? | 62 (97) | |
| Outbreak characteristics | c) Number of patients admitted during outbreak | 43 (67) |
| d) Distributions provided for patient demographics | 38 (59) | |
| e) Proportion admitted from other hospitals, wards, communities, etc. | 26 (41) | |
| f) Potential risk factors for acquiring organism included | 46 (72) | |
| g) Case definitions for outbreaks were included | 54 (84) | |
| h) Proportions of patient outcomes were included (eg, ICU, hospitalization, mortality) | 49 (77) | |
| Outbreak location/setting | i) Description of unit, hospital, community. | 29 (45) |
| Organization of patient and sample data | j) Provide eligibility criteria for selection of cases, participants and/or controls (more for cohort/case‐control) | 54 (84) |
| k) Provide number of exposed/unexposed (cohort) or controls per case (case‐control) | 19 (30) | |
| l) Describe any efforts to address potential sources of bias | 17 (27) | |
| m) Explain how the final study size was arrived at (or patient/case count) | 62 (97) | |
| n) Explain how missing data were addressed | 3 (5) | |
| o)Describe any sensitivity analysis | 0 (0) | |
| 4) Results | a) Consider use of a flow diagram to depict patient or participant count at each stage of investigation | 52 (81) |
| b) DescriptiveGive characteristics of study participants (eg, demographic, clinical, social) + information on exposures and any other associative factors | 53 (83) | |
| c) Timeline: charts to display duration of patient stay, date of detecting organisms, etc. | 28 (44) | |
| d) Consideration of any confounding variables (eg, use of antibiotics, length of stay changes) | 47 (73) | |
| e) Further results and analysesIf applicable, provided unadjusted and confounder‐adjusted estimates with confidence intervals. | (25) | |
| 5) Discussion | a) Clinical signification of observations was considered and hypotheses were reviewed in relation to the findings. | 63 (98) |
| b) Discuss limitations of study, accounting for any potential bias. | 43 (67) | |
| c) Discussed generalizability (external validity) of findings and applicability with current evidence | 59 (92) |
Predictors for reporting quality univariate and multivariate analysis
| Predictor Variables | Comparison Groups | Modified STROBE Mean Score (SD) | Mean Difference (95% CI) |
|
|
|---|---|---|---|---|---|
| Publication year | 2009+ | 20.43 (3.27) | 3.43 (0.86 to 6.00) | .010 | .076 |
| −2009 | 17.00 (4.28) | ||||
| Journal type | Peer‐reviewed | 20.65 (3.23) | 2.79 (0.79 to 4.78) | .007 | .034 |
| Epidemiologic Report | 17.87 (3.85) | ||||
| Affiliation | Public Health | 20.49 (3.62) | 1.65 (−0.27 to 3.56) | .091 | .035 |
| Academic Institution | 18.84 (3.20) | ||||
| Outbreak size | By increase of 10 patients | 20.00 (3.56) | n/a | .085 | .244 |
| Outbreak location (Continent) | North America, Europe | 19.97 (3.48) | −0.06 (−1.86 to 1.73) | .945 | ‐ |
| Africa, Asia, South America, Oceania | 20.03 (3.69) | ||||
| Influenza strain | H1N1 | 20.44 (3.13) | 1.49 (−0.76 to 3.75) | .184 | ‐ |
| Avian, Seasonal | 18.95 (4.33) | ||||
| Outbreak setting | Hospital | 20.78 (3.26) | 1.08 (−0.89 to 3.06) | .278 | ‐ |
| Community | 19.70 (3.66) |
CI, confidence intervals; SD, standard deviation; ‐, not applicable.